•Crescita Therapeutics obtained a final court order from the Ontario Superior Court of Justice approving its plan of arrangement with ClinActiv Holdings.
•Bitwise CIO Matt Hougan argued HYPE is undervalued, claiming the market misprices Hyperliquid's business model as just another perpetual futures venue.
•Bitwise recently launched a HYPE-based ETF and announced it will use a portion of generated fees to purchase the token.
